Jeffrey Bluestone
Director at Gilead Sciences, Inc. (GILD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 1,165 | $143.75 | $167K | +0.6% |
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 1,816 | $144.92 | $263K | -0.2% |
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 1,658 | $145.73 | $242K | -0.8% |
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 26 | $146.36 | $4K | -1.2% |
| Aug 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 335 | $146.26 | $49K | -1.1% |
| Jan 21SEC | GILDGilead Sciences, Inc. | Sell Plan | 5,000 | $123.50 | $618K | +17.1% |
| Dec 1SEC | GILDGilead Sciences, Inc. | Sell | 5,000 | $125.08 | $625K | +15.6% |
- Sell
Director Jeffrey Bluestone sold $167K of GILD at $143.75 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $263K of GILD at $144.92 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $242K of GILD at $145.73 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $4K of GILD at $146.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $49K of GILD at $146.26 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Jeffrey Bluestone sold $618K of GILD at $123.50 — cuts the stake by 36%; pre-scheduled 10b5-1 plan sale.